Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Zacks Investment Research on MSN7d
DXCM Stock Gains Following New Data on Upcoming G7 CGM SensorDexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost competitive advantage. Over the past six months, DexCom has been a great ...
The report surveyed over 2,500 people ... During the conference, first-ever accuracy and performance data for Dexcom G7 15 Day,1 will be presented, showcasing an overall mean absolute relative ...
DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous ... improvement over previous versions (10 days), offering users a longer lifespan per sensor, thereby reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback